USFDA Withdrwas Sales Ban as Indian Pharma Companies Take Corrective Measures
A new recommendation has come in for the Indian drug companies. Most Indian drug companies that were penalised for violating […]
Say something
Tags: Aurobindo Pharma Ltd, Cadila Healthcare, cancer, Centrum Broking, CEO, Claris Lifesciences Limited, DAIICHI SANKYO COMPANY LIMITED, Daiichi-Sankyo, drug maker, food and drug administration, Health/Medical/Pharmaceuticals, Hyderabad, India, lower healthcare cost, manufacturing norms, manufacturing processes, pharmaceutical, Pharmaceutical sciences, Pharmacology, Ranbaxy Laboratories, Secretary General, Sun Pharmaceuticals Industries Ltd, United States, USD, utive
-
-
Flipkart Health+ App Launched
06-04-2022
